Nvidia Confirms Major OpenAI Investment Amid AI Funding Race 
Palantir Stock Jumps After Strong Q4 Earnings Beat and Upbeat 2026 Revenue Forecast 
Federal Judge Clears Way for Jury Trial in Elon Musk’s Fraud Lawsuit Against OpenAI and Microsoft 
Panama Supreme Court Voids CK Hutchison Port Concessions, Raising Geopolitical and Trade Concerns 
Boeing Secures New Labor Contract With Former Spirit AeroSystems Employees 
Panama Supreme Court Voids Hong Kong Firm’s Panama Canal Port Contracts Over Constitutional Violations 
CSPC Pharma and AstraZeneca Forge Multibillion-Dollar Partnership to Develop Long-Acting Peptide Drugs 
Using the Economic Calendar to Reduce Surprise Driven Losses in Forex 
Qantas to Sell Jetstar Japan Stake as It Refocuses on Core Australian Operations 
DOJ Urges Judge to Block Lawmakers’ Bid for Special Master in Jeffrey Epstein Records Case 
Disney Board Nears CEO Decision as Josh D’Amaro Emerges as Leading Candidate 
Tesla Launches New Model Y Variant in the US Starting at $41,990 
Federal Judge Signals Possible Dismissal of xAI Lawsuit Against OpenAI 
Nvidia’s $100 Billion OpenAI Investment Faces Internal Doubts, Report Says 
NRW Holdings Shares Surge After Securing Major Rio Tinto Contract and New Project Wins 
Google Seeks Delay on Data-Sharing Order as It Appeals Landmark Antitrust Ruling 
Elon Musk Seeks $134 Billion in Lawsuit Against OpenAI and Microsoft Over Alleged Wrongful Gains 
 to Recover Losses Announced by Shareholders Foundation - EconoTimes)
The Shareholders Foundation, Inc. announces that a lawsuit was filed in Oregon on behalf of certain purchasers of shares of GNC Holdings Inc (NYSE:GNC) over alleged Securities Laws Violations by GNC Holdings.
Investors who purchased shares of GNC Holdings Inc (NYSE:GNC) have certain options and for certain investors are short and strict deadlines running. Deadline: December 28, 2015. NYSE: GNC investors should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554.
The plaintiff claims that the defendants issued materially false and misleading statements to investors and/or failed to disclose that GNC Holdings unlawfully sold thousands of units of products in Oregon that contained picamilon, that GNC Holdings unlawfully sold thousands of units of products in Oregon that contained BMPEA, and that as a result of the foregoing, GNC Holdings’ public statements were materially false and misleading at all relevant times.
On October 22, 2015, the State of Oregon sued GNC Holdings Inc, claiming that the company's nutritional and dietary supplements are laced with unapproved drugs, including picamilon and BMPEA. According to the complaint GNC Holdings Inc violated the Oregon Unlawful Trade Practices ACT (“UTPA”) by misrepresenting some of its products as lawful dietary supplements. The complaint alleges that certain products that were misrepresented are unapproved drugs that may not be lawfully sold in the United States as a dietary supplement. In addition, the complaint alleged that GNC Holdings Inc sold products labeled containing botanical acacia rigidula that were added with unlabeled BMPEA and that GNC Holdings Inc allegedly sold thousands of units of products containing picamilon or BMPEA that were falsely labeled as a dietary supplement.
Those who purchased GNC Holdings Inc (NYSE:GNC) shares have certain options and should contact the Shareholders Foundation, Inc. by e-mail at [email protected] or call +1 (858) 779-1554.
The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
